miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.
about
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway.Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway.miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.Analysis of the complex interaction of CDR1as-miRNA-protein and detection of its novel role in melanoma.A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy.Biological role of miR-204 and miR-211 in melanomaSuppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown SystemNew insights in melanoma resistance to BRAF inhibitors: a role for microRNAs
P2860
Q37682826-5649EF01-C4A8-4EFA-9795-4281F957967BQ37718177-FBCEE6CA-16A0-40C1-B0BE-97988CF0CEAEQ38710426-25317360-0F11-4A9C-9C82-59704F372328Q42367926-9F31982A-BC76-44C6-A4ED-900408FF29A7Q47616712-036EB2CB-6222-4EE2-AEDC-50DD4A503B35Q48293862-4252E4B9-1DDA-4E67-A3EC-03CFC3293597Q49921953-372F782E-782D-44FE-BF7D-6296C2C3F470Q50062795-17AE5B05-DF0A-42CB-9D6A-469C5E735FA3Q55031130-ED360A7A-8B5C-4AAA-9169-A41DBBAABC2FQ55431301-D4E81570-9387-4F81-9F29-8CE81B321981Q55487384-932E3764-42AE-4769-853A-E7B131D888FDQ58718139-85D0DE65-56CE-4B00-9DBF-E2E42F17AA6FQ58776511-C563B3C5-8665-4EEB-A423-70089AB9A662Q59136531-4F3BFC59-255A-43EE-806F-1C02681B0124
P2860
miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@en
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@nl
type
label
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@en
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@nl
prefLabel
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@en
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@nl
P2093
P2860
P356
P1433
P1476
miR-7 reverses the resistance ...... d PI3K/AKT signaling pathways.
@en
P2093
Guanxin Shen
Liyun Dong
Xiaoyan Sun
Yanhong Sun
P2860
P304
53558-53570
P356
10.18632/ONCOTARGET.10669
P407
P577
2016-07-18T00:00:00Z